PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
XLV vs. PFE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


XLVPFE
YTD Return3.00%-10.45%
1Y Return7.45%-31.06%
3Y Return (Ann)6.18%-9.40%
5Y Return (Ann)11.39%-4.03%
10Y Return (Ann)10.99%1.96%
Sharpe Ratio0.76-1.30
Daily Std Dev10.59%23.79%
Max Drawdown-39.18%-69.72%
Current Drawdown-5.26%-54.57%

Correlation

-0.50.00.51.00.6

The correlation between XLV and PFE is 0.61, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

XLV vs. PFE - Performance Comparison

In the year-to-date period, XLV achieves a 3.00% return, which is significantly higher than PFE's -10.45% return. Over the past 10 years, XLV has outperformed PFE with an annualized return of 10.99%, while PFE has yielded a comparatively lower 1.96% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%200.00%400.00%600.00%800.00%NovemberDecember2024FebruaryMarchApril
705.93%
54.09%
XLV
PFE

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Health Care Select Sector SPDR Fund

Pfizer Inc.

Risk-Adjusted Performance

XLV vs. PFE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Health Care Select Sector SPDR Fund (XLV) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


XLV
Sharpe ratio
The chart of Sharpe ratio for XLV, currently valued at 0.76, compared to the broader market-1.000.001.002.003.004.000.76
Sortino ratio
The chart of Sortino ratio for XLV, currently valued at 1.15, compared to the broader market-2.000.002.004.006.008.001.15
Omega ratio
The chart of Omega ratio for XLV, currently valued at 1.13, compared to the broader market0.501.001.502.002.501.13
Calmar ratio
The chart of Calmar ratio for XLV, currently valued at 0.69, compared to the broader market0.002.004.006.008.0010.000.69
Martin ratio
The chart of Martin ratio for XLV, currently valued at 2.50, compared to the broader market0.0020.0040.0060.002.50
PFE
Sharpe ratio
The chart of Sharpe ratio for PFE, currently valued at -1.30, compared to the broader market-1.000.001.002.003.004.00-1.30
Sortino ratio
The chart of Sortino ratio for PFE, currently valued at -1.92, compared to the broader market-2.000.002.004.006.008.00-1.92
Omega ratio
The chart of Omega ratio for PFE, currently valued at 0.78, compared to the broader market0.501.001.502.002.500.78
Calmar ratio
The chart of Calmar ratio for PFE, currently valued at -0.56, compared to the broader market0.002.004.006.008.0010.00-0.56
Martin ratio
The chart of Martin ratio for PFE, currently valued at -1.43, compared to the broader market0.0020.0040.0060.00-1.43

XLV vs. PFE - Sharpe Ratio Comparison

The current XLV Sharpe Ratio is 0.76, which is higher than the PFE Sharpe Ratio of -1.30. The chart below compares the 12-month rolling Sharpe Ratio of XLV and PFE.


Rolling 12-month Sharpe Ratio-2.00-1.000.001.002.00NovemberDecember2024FebruaryMarchApril
0.76
-1.30
XLV
PFE

Dividends

XLV vs. PFE - Dividend Comparison

XLV's dividend yield for the trailing twelve months is around 1.57%, less than PFE's 6.50% yield.


TTM20232022202120202019201820172016201520142013
XLV
Health Care Select Sector SPDR Fund
1.57%1.59%1.47%1.33%1.49%2.16%1.56%1.46%1.59%1.43%1.34%1.51%
PFE
Pfizer Inc.
6.50%5.70%3.12%2.64%3.71%3.49%2.96%3.35%3.51%3.29%3.17%2.97%

Drawdowns

XLV vs. PFE - Drawdown Comparison

The maximum XLV drawdown since its inception was -39.18%, smaller than the maximum PFE drawdown of -69.72%. Use the drawdown chart below to compare losses from any high point for XLV and PFE. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2024FebruaryMarchApril
-5.26%
-54.57%
XLV
PFE

Volatility

XLV vs. PFE - Volatility Comparison

The current volatility for Health Care Select Sector SPDR Fund (XLV) is 3.45%, while Pfizer Inc. (PFE) has a volatility of 5.96%. This indicates that XLV experiences smaller price fluctuations and is considered to be less risky than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%NovemberDecember2024FebruaryMarchApril
3.45%
5.96%
XLV
PFE